News
Search All News
Top Stories
-
Source:
Columbia Medicine MagazineDr. Neil Shneider, MD, PhD, director of the Eleanor and Lou Gehrig ALS Center, requested a one-time experimental therapy treatment through the FDA which has evolved into a multicenter clinical trial.
Topic
Research -
Patients at Columbia are pursuing custom-designed ASO therapies. These compounds lend themselves to personalization.
-
Wings over Wall Street gala for the MDA research program on ALS honored Dr. Shneider with the Diamond Award. In recognition of his scientific leadership and dedication to the eradication of ALS.
-
Source:
Today ShowSee Dr. Shneider's interview with Today show reflecting on the efforts to find a cure and treatments through the continued work of our team at the Columbia Eleanor & Lou Gehrig ALS Center.
